In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 2, p. 142, doi. 10.1038/sj.cgt.7700407
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2002 AND VI 9 AND IP 2
Results: 13
1
2
Connexin 43–mediated bystander effect in two rat glioma cell models.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 2, p. 149, doi. 10.1038/sj.cgt.7700411
- By:
- Publication type:
- Article
3
Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 2, p. 117, doi. 10.1038/sj.cgt.7700416
- By:
- Publication type:
- Article
4
A convenient cancer vaccine therapy with in vivo transfer of interleukin 12 expression plasmid using gene gun technology after priming with irradiated carcinoma cells.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 2, p. 156, doi. 10.1038/sj.cgt.7700419
- By:
- Publication type:
- Article
5
Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 2, p. 164, doi. 10.1038/sj.cgt.7700420
- By:
- Publication type:
- Article
6
Gene transfection by quantitatively reconstituted Sendai envelope proteins into liposomes.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 2, p. 173, doi. 10.1038/sj.cgt.7700421
- By:
- Publication type:
- Article
7
Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: Implications for pharmacogene therapy.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 2, p. 178, doi. 10.1038/sj.cgt.7700422
- By:
- Publication type:
- Article
8
Transrectal gene therapy of the prostate in the canine model.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 2, p. 189, doi. 10.1038/sj.cgt.7700425
- By:
- Publication type:
- Article
9
Gene therapy of melanoma pulmonary metastasis by intramuscular injection of plasmid DNA encoding tissue inhibitor of metalloproteinases-1.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 2, p. 126, doi. 10.1038/sj.cgt.7700426
- By:
- Publication type:
- Article
10
Alternative splicing as a novel of means of regulating the expression of therapeutic genes.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 2, p. 133, doi. 10.1038/sj.cgt.7700427
- By:
- Publication type:
- Article
11
VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 2, p. 197, doi. 10.1038/sj.cgt.7700428
- By:
- Publication type:
- Article
12
Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8<sup>+</sup> cytotoxic T-cell activation and antitumor immunity.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 2, p. 202, doi. 10.1038/sj.cgt.7700429
- By:
- Publication type:
- Article
13
Expression of the prodrug-activating enzyme DT-diaphorase via Ad5 delivery to human colon carcinoma cells in vitro.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 2, p. 209, doi. 10.1038/sj.cgt.7700430
- By:
- Publication type:
- Article